- An updated drug list from Cigna (NYSE:CI) shows Mylan's (NASDAQ:MYL) EpiPen as no longer covered and non-preferred as of Jan. 7.
- Mylan fell 4.3% during the regular session and is flat in thin after hours action.
- Previously: Trump says he'll slash drug prices through federal bidding (Jan. 11)
- Previously: Allergan CEO also has a Twitter account (Jan. 11)